Earlier warning: A multi-indicator approach to monitoring trends in the illicit use of medicines

International Journal of Drug Policy

Volumn 20, Issue 2, 2009, Pages 161-169

  Mounteney, Jane ^a   Haugland, Siren ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Illicit use of medicines; Monitoring; Multi indicator approach; Trends

Indexed keywords

ALPRAZOLAM; BUPRENORPHINE; DIAZEPAM; FLUNITRAZEPAM; ILLICIT DRUG;

ARTICLE; DRUG MISUSE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HUMAN; NORWAY; PHARMACY; PRIORITY JOURNAL; TREND STUDY;

BUPRENORPHINE; DATA COLLECTION; FLUNITRAZEPAM; HUMANS; MODELS, THEORETICAL; NORWAY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 58549094280     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.09.006     Document Type: Article

References (43)

1. Bramnes J.G., Skurtveit S., Furu K., Engeland A., Sakshaug S., and Ronning M. Changes in the sale and use of flunitrazepam in Norway after 1999. Tidskrift Norsk Laegeforen 126 5 (2006) 589-590
2. Creswell J. Research design. Qualitative, quantitative and mixed method approaches (2003), Sage
3. Dale A., and Jones S. The methadone experience (1992), The Centre for Research on Drugs and Health Behaviour, London
4. Darke S. The use of benzodiazepines among injecting drug users. Drug Alcohol Review 13 (1994) 63-69
5. Degenhardt, L., & Dietze, P. (2005). Monograph No. 10: Data sources on illicit drug use and harm in Australia. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre.
6. Degenhardt L., Black E., Breen C., Bruno R., Kinner S., Roxburgh A., et al. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug and Alcohol Review 25 (2006) 403-412
7. Denzin N.K. The research act: A theoretical introduction to sociological methods (1978), Aldine, Chicago
8. EMCDDA. (1997). Estimating the Prevalence of Problem Drug Use in Europe. EMCDDA Scientific Monograph. No. 1. Lisbon.
9. EMCDDA. (2005). EMCDDA Thematic Papers-Youth Media. Lisbon.
10. Fountain J., Strang J., Gossop M., Farrell M., and Griffiths P. Diversion of prescribed drugs by drug users in treatment: Analysis of the UK market and new data from London. Addiction 95 3 (2000) 393-406
11. Fry C., and Bruno R. Recent trends in benzodiazepine use by injecting drug users in Victoria and Tazmania. Drug Alcohol Review 21 (2002) 363-367
12. Ghodse H. Drugs and addictive behaviour: A guide to treatment. 2nd ed. (1995), Blackwell, Oxford
13. Griffiths P., Vingoe L., Hunt N., Mounteney J., and Hartnoll R. Drug information systems, early warning and new drug trends: Can drug monitoring systems become more sensitive to emerging trends in drug consumption?. Substance Use Misuse 35 6-8 (2000) 811-844
14. Hando J., Darke S., and O'Brien S. The development of an early warning system to detect trends in illicit drug use in Australia: The illicit drug reporting system. Addiction Research 6 (1998) 97-113
15. Hartnoll, R., Avico, U., Ingold, F., Lange, K., Lenke, L., & O'Hare, A., et al. (1989). A multi-city study of drug misuse in Europe. UNODC Bulletin.
16. Hartnoll R., Hendriks V., and Morrival M. The assessment of drug problems (1998), WHO Regional Office for Europe
17. INCB. (2007). The Report of the International Narcotics Control Board for 2006. United Nations (E/INCB/2006/1).
18. Inciardi, J. (1977). Methadone diversion: Experiences and issues. US Department of Health, Education and Welfare publication No. (ADM) 77-488. Washington, DC.
19. Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2007). Monitoring the Future national results on adolescent drug use: Overview of key findings, 2006 (NIH Publication No. 07-6202). Bethesda, MD: National Institute on Drug Abuse, 71 pp.
20. Kelle, U. (2001). Sociological explanations between micro and macro and the integration of qualitative and quantitative methods. Forum: Qualitative Social Research, Vol. 2, No. 1.
21. Korf D., and Nabben T. Antenna: A multi-method approach to assessing new drug trends in EMCDDA understanding and responding to drug use: The role of qualitative research (2002), European Monitoring Centre for Drugs and Drug Addiction, Lisbon
22. Kumar, K. (1989). Conducting key informant interviews in developing countries. A.I.D. program design and evaluation. Methodology report no. 13. Agency for International Development.
23. Lislevand H. Rohypnol (flunitrazepam) tabletter 1 mg avregistreres fra og med 1. august 2004. Nytt om legemidler 27 (2004) 34
24. Maxwell J. Trends in the abuse of prescription drugs (2006), Gulf Coast Addiction Technology Transfer Center, Texas
25. McKeganey N. Shadowland: General practitioners and the treatment of opiate abusing patients. British Journal of Addiction 83 (1988) 373-386
26. Mitchell E. Multiple triangulation: A methodology for nursing science. Advances in Nursing Science 8 3 (1986) 18-26
27. Morse J.M. Approaches to qualitative-quantitative methodological triangulation. Nursing Research 40 (1991) 120-123
28. Morse J.M. Principles of mixed methods and multimethod research design. In: Tashakkori A., and Teddlie C. (Eds). Handbook of mixed method (2003), Sage, Thousand Oaks
29. Mounteney J., and Leirvåg S.-E. Føre Var report-Spring 2002 (2002), Bergen Clinics Foundation, Norway
30. Mounteney J., and Leirvåg S.-E. Providing an earlier warning of emerging drug trends: The Føre Var system. Drugs: Education, Prevention and Policy 11 6 (2004) 449-471
31. Mounteney J., and Leirvåg S.-E. Føre Var report-autumn 2005 (2005), Bergen Clinics Foundation, Norway
32. NIDA. (2005). Epidemiological Trends in Drug Abuse. CEWG Advance Report and Highlights/Executive Summary: Abuse of Stimulants and Other Drugs. NIDA.
33. Office of Applied Studies. (2006). Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-28, DHHS Publication No. (SMA) 06-4143, Rockville MD, April 2006.
34. Oliver P., Keen J., Rowse G., and Mathers N. Deaths from drugs of abuse in Sheffield, 1998: The role of prescribed medication. The British Journal of General Practice 51 466 (2001) 394-396
35. Parry C., Bhana A., Plüddemann A., Myers B., Siegfried N., Morojele N., et al. The South African Community Epidemiology Network on Drug Use (SACENDU): Description, findings (1997-99) and policy implications. Addiction 97 (2002) 969-976
36. Rhodes T., Kumar S.M., and Fitch C. Special issue: Rapid assessment and response. International Journal of Drug Policy 11 (2000)
37. SAMHSA. (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies.
38. Sirus. (2006). 2006 National report to the EMCDDA 'Norway'. Norwegian Institute of Alcohol and Drug Research, SIRUS.
39. Steen J. Rohypnolmarkedet forandret. Motgift (2004) 01
40. Strang J., Griffiths P., Abbey J., and Gossop M. Survey of injected benzodiazepines among drug users I Britain. BMJ 308 (1994) 1082
41. Strang J., Griffiths P., Powes B., Fountain J., Williamson S., and Gossop M. Which drugs cause overdose amongst opiate misusers? A study of personal and witnessed overdoses. Drugs and Alcohol Review 18 (1999) 253-261
42. Streiner D., and Norman G.R. Health measurement scales: A practical guide to their development and use (1989), Oxford University Press, Oxford
43. van de Mheen H., Coumans M., Barendregt A., and van der Poel A. A Drug Monitoring System: Keeping a finger on the pulse by triangulation of qualitative and quantitative methods. Addiction Research and Theory 14 5 (2006) 461-473